학술논문
First dose-finding study in cancer patients (pts) of a potent, selective, allosteric AKT inhibitor MK2206 (MK), incorporating pharmacodynamic (PD) and predictive biomarkers and showing profound pathway blockade
Document Type
Journal
Author
Yap, Timothy A.; Papadopoulos, Kyriakos; Fearen, Ivy; Carpenter, Christopher; Delgado, Liliana; Taylor, Adekemi; Olmos, David; Brunetto, Andre; Tall, Matthew; Decordova, Shaun; Walton, Mike I.; Heaton, Simon P.; Garrett, Michelle D.; Domsch, Julia; Patnaik, Amita; Sullivan, Daniel; Yan, Li; de Bono, Johann S.; Tolcher, Anthony W.
Source
Subject
Language
English
ISSN
15387445